s6y
Company name or ticker
Search
Pivotal bioVenture Partners Fund I U.G.P. Ltd
3
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, July 23, 2020
Period
Jul 23, 2020
Accession number
0001012975-20-000661
Documents
PRIMARY DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header